BIOMAT Database Logo BIOMAT Database Logo

Two novel low-density lipoprotein receptor gene mutations (E397X and 347delGCC) in St. Petersburg familial hypercholesterolemia. 1998

K Chakir, and C Kh, and M M Ju, and S P Shevtsov, and V I Golubkov, and N A Skobeleva, and Y A Shur, and F M Zakharova, and B M Lipovetskyi, and V O Konstantinov, and A D Denisenko, and V S Gaitskhoki, and E I Schwartz
Petersburg Nuclear Physics Institute, Russian Academy of Sciences, Gatchina, 188350, Russia.

Familial hypercholesterolemia (FH), a monogenic disease known to be caused by low-density lipoprotein receptor (LDLR) gene mutations, results in the development of premature atherosclerosis and coronary artery disease in affected individuals. The spectrum of LDLR gene mutations in Russia is poorly known. Using polymerase chain reaction (PCR)-single-strand conformational polymorphism (SSCP) analysis, followed by DNA sequencing, we have screened selected exons of the LDLR gene in 80 unrelated St. Petersburg FH patients for the presence of mutations. Two new LDLR gene mutations, 347delGCC and E397X, were characterized among individuals with familial hypercholesterolemia in St. Petersburg. The carriers of both mutations possessed highly elevated blood serum cholesterol. Cosegregation of E397X mutation and LDLR gene RFLP haplotypes with hyperlipidemia was demonstrated by family study. Both mutations seem to be specific to Slavic patients.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010375 Pedigree The record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition. Family Tree,Genealogical Tree,Genealogic Tree,Genetic Identity,Identity, Genetic,Family Trees,Genealogic Trees,Genealogical Trees,Genetic Identities,Identities, Genetic,Tree, Family,Tree, Genealogic,Tree, Genealogical,Trees, Family,Trees, Genealogic,Trees, Genealogical
D011973 Receptors, LDL Receptors on the plasma membrane of nonhepatic cells that specifically bind LDL. The receptors are localized in specialized regions called coated pits. Hypercholesteremia is caused by an allelic genetic defect of three types: 1, receptors do not bind to LDL; 2, there is reduced binding of LDL; and 3, there is normal binding but no internalization of LDL. In consequence, entry of cholesterol esters into the cell is impaired and the intracellular feedback by cholesterol on 3-hydroxy-3-methylglutaryl CoA reductase is lacking. LDL Receptors,Lipoprotein LDL Receptors,Receptors, Low Density Lipoprotein,LDL Receptor,LDL Receptors, Lipoprotein,Low Density Lipoprotein Receptor,Low Density Lipoprotein Receptors,Receptors, Lipoprotein, LDL,Receptor, LDL,Receptors, Lipoprotein LDL
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006938 Hyperlipoproteinemia Type II A group of familial disorders characterized by elevated circulating cholesterol contained in either LOW-DENSITY LIPOPROTEINS alone or also in VERY-LOW-DENSITY LIPOPROTEINS (pre-beta lipoproteins). Hyperbetalipoproteinemia,Hypercholesterolemia, Essential,Hypercholesterolemia, Familial,Apolipoprotein B-100, Familial Defective,Apolipoprotein B-100, Familial Ligand-Defective,Familial Combined Hyperlipoproteinemia,Hyper-Low Density Lipoproteinemia,Hyper-Low-Density-Lipoproteinemia,Hyper-beta-Lipoproteinemia,Hypercholesterolemia, Autosomal Dominant,Hypercholesterolemia, Autosomal Dominant, Type B,Hypercholesterolemic Xanthomatosis, Familial,Hyperlipoproteinemia Type 2,Hyperlipoproteinemia Type IIa,Hyperlipoproteinemia Type IIb,Hyperlipoproteinemia, Type II,Hyperlipoproteinemia, Type IIa,LDL Receptor Disorder,Apolipoprotein B 100, Familial Defective,Apolipoprotein B 100, Familial Ligand Defective,Autosomal Dominant Hypercholesterolemia,Autosomal Dominant Hypercholesterolemias,Combined Hyperlipoproteinemia, Familial,Combined Hyperlipoproteinemias, Familial,Density Lipoproteinemia, Hyper-Low,Density Lipoproteinemias, Hyper-Low,Disorder, LDL Receptor,Disorders, LDL Receptor,Dominant Hypercholesterolemia, Autosomal,Dominant Hypercholesterolemias, Autosomal,Essential Hypercholesterolemia,Essential Hypercholesterolemias,Familial Combined Hyperlipoproteinemias,Familial Hypercholesterolemia,Familial Hypercholesterolemias,Familial Hypercholesterolemic Xanthomatoses,Familial Hypercholesterolemic Xanthomatosis,Hyper Low Density Lipoproteinemia,Hyper beta Lipoproteinemia,Hyper-Low Density Lipoproteinemias,Hyper-Low-Density-Lipoproteinemias,Hyper-beta-Lipoproteinemias,Hyperbetalipoproteinemias,Hypercholesterolemias, Autosomal Dominant,Hypercholesterolemias, Essential,Hypercholesterolemias, Familial,Hypercholesterolemic Xanthomatoses, Familial,Hyperlipoproteinemia Type 2s,Hyperlipoproteinemia Type IIas,Hyperlipoproteinemia Type IIbs,Hyperlipoproteinemia Type IIs,Hyperlipoproteinemia, Familial Combined,Hyperlipoproteinemias, Familial Combined,Hyperlipoproteinemias, Type II,Hyperlipoproteinemias, Type IIa,LDL Receptor Disorders,Lipoproteinemia, Hyper-Low Density,Lipoproteinemias, Hyper-Low Density,Receptor Disorder, LDL,Receptor Disorders, LDL,Type 2, Hyperlipoproteinemia,Type II Hyperlipoproteinemia,Type II Hyperlipoproteinemias,Type IIa Hyperlipoproteinemia,Type IIa Hyperlipoproteinemias,Xanthomatoses, Familial Hypercholesterolemic,Xanthomatosis, Familial Hypercholesterolemic
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

K Chakir, and C Kh, and M M Ju, and S P Shevtsov, and V I Golubkov, and N A Skobeleva, and Y A Shur, and F M Zakharova, and B M Lipovetskyi, and V O Konstantinov, and A D Denisenko, and V S Gaitskhoki, and E I Schwartz
Two novel slavic point mutations in the low-density lipoprotein receptor gene in patients with familial hypercholesterolemia from St. Petersburg, Russia.
January 1998, Molecular genetics and metabolism,
K Chakir, and C Kh, and M M Ju, and S P Shevtsov, and V I Golubkov, and N A Skobeleva, and Y A Shur, and F M Zakharova, and B M Lipovetskyi, and V O Konstantinov, and A D Denisenko, and V S Gaitskhoki, and E I Schwartz
Familial hypercholesterolemia in St-Petersburg: the known and novel mutations found in the low density lipoprotein receptor gene in Russia.
February 2005, BMC medical genetics,
K Chakir, and C Kh, and M M Ju, and S P Shevtsov, and V I Golubkov, and N A Skobeleva, and Y A Shur, and F M Zakharova, and B M Lipovetskyi, and V O Konstantinov, and A D Denisenko, and V S Gaitskhoki, and E I Schwartz
Two novel and two known low-density lipoprotein receptor gene mutations in German patients with familial hypercholesterolemia.
January 1998, Human mutation,
K Chakir, and C Kh, and M M Ju, and S P Shevtsov, and V I Golubkov, and N A Skobeleva, and Y A Shur, and F M Zakharova, and B M Lipovetskyi, and V O Konstantinov, and A D Denisenko, and V S Gaitskhoki, and E I Schwartz
Two common low density lipoprotein receptor gene mutations cause familial hypercholesterolemia in Afrikaners.
September 1989, The Journal of clinical investigation,
K Chakir, and C Kh, and M M Ju, and S P Shevtsov, and V I Golubkov, and N A Skobeleva, and Y A Shur, and F M Zakharova, and B M Lipovetskyi, and V O Konstantinov, and A D Denisenko, and V S Gaitskhoki, and E I Schwartz
Mutations of the low-density-lipoprotein receptor gene and familial hypercholesterolemia.
August 1994, Trends in endocrinology and metabolism: TEM,
K Chakir, and C Kh, and M M Ju, and S P Shevtsov, and V I Golubkov, and N A Skobeleva, and Y A Shur, and F M Zakharova, and B M Lipovetskyi, and V O Konstantinov, and A D Denisenko, and V S Gaitskhoki, and E I Schwartz
Novel mutations of low-density lipoprotein receptor gene in China patients with familial hypercholesterolemia.
May 2015, Applied biochemistry and biotechnology,
K Chakir, and C Kh, and M M Ju, and S P Shevtsov, and V I Golubkov, and N A Skobeleva, and Y A Shur, and F M Zakharova, and B M Lipovetskyi, and V O Konstantinov, and A D Denisenko, and V S Gaitskhoki, and E I Schwartz
A novel deletion in the low-density lipoprotein receptor gene in a patient with familial hypercholesterolemia from Petersburg.
January 1993, Human mutation,
K Chakir, and C Kh, and M M Ju, and S P Shevtsov, and V I Golubkov, and N A Skobeleva, and Y A Shur, and F M Zakharova, and B M Lipovetskyi, and V O Konstantinov, and A D Denisenko, and V S Gaitskhoki, and E I Schwartz
[Screening for low-density lipoprotein receptor gene mutations in familial hypercholesterolemia Chinese].
September 2004, Zhonghua nei ke za zhi,
K Chakir, and C Kh, and M M Ju, and S P Shevtsov, and V I Golubkov, and N A Skobeleva, and Y A Shur, and F M Zakharova, and B M Lipovetskyi, and V O Konstantinov, and A D Denisenko, and V S Gaitskhoki, and E I Schwartz
Mutations in the low-density lipoprotein receptor gene in Chinese familial hypercholesterolemia patients.
October 1998, Arteriosclerosis, thrombosis, and vascular biology,
K Chakir, and C Kh, and M M Ju, and S P Shevtsov, and V I Golubkov, and N A Skobeleva, and Y A Shur, and F M Zakharova, and B M Lipovetskyi, and V O Konstantinov, and A D Denisenko, and V S Gaitskhoki, and E I Schwartz
Functional characterization of two low-density lipoprotein receptor gene mutations in two Chinese patients with familial hypercholesterolemia.
January 2014, PloS one,
Copied contents to your clipboard!